Toxic leukoencephalopathy is structural damage to the cerebral white matter as a result of exposure to a toxic substance. Damage occurs secondary to disruption of central nervous system myelin. Toxic leukoencephalopathy can occur after exposure to multiple agents including cranial radiation, chemotherapeutic agents, immunosuppressive drugs, antifungal agents, alcohol, illicit drugs, and environmental toxins such as carbon monoxide. Patients of any age can be affected after exposure to a leukotoxic agent. Symptoms may be acute and temporally related to a toxic exposure but are often chronic or delayed. Hypoxia from carbon monoxide poisoning, for example, can cause delayed posthypoxic leukoencephalopathy, as can drug overdoses, complications of general anesthesia, asphyxiation from strangulation, and hemorrhagic shock.
Patients may present with a variety of neurologic symptoms including behavioral or personality changes, memory impairment, and language and cognitive dysfunction. Focal symptoms are an uncommon finding. Due to nonspecific findings, patients may be misdiagnosed with psychiatric disease. Prognosis depends on the particular leukotoxin the patient was exposed to, the duration of exposure, and the degree of injury. While improvement often occurs, recovery is rarely complete.
Emergency: requires immediate attention
Toxic leukoencephalopathy
Alerts and Notices
Synopsis

Codes
ICD10CM:
R90.82 – White matter disease, unspecified
SNOMEDCT:
722602003 – White matter disorder caused by toxin
R90.82 – White matter disease, unspecified
SNOMEDCT:
722602003 – White matter disorder caused by toxin
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
- Hypoxic-ischemic injury
- Reversible posterior leukoencephalopathy
- Progressive multifocal leukoencephalopathy
- Hypertensive encephalopathy
- Leukodystrophies
- Acquired immunodeficiency syndrome (AIDS) dementia complex
- Central nervous system lymphoma
- Radiation-induced leukoencephalopathy
- Uremia
- Phenylketonuria
- Krabbe disease
- Post-transplant leukoencephalopathy
- Acute demyelinating encephalomyelitis
- Multiple sclerosis
- Subacute sclerosing panencephalitis
- Trauma with diffuse axonal injury
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
Drug Reaction Data
Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.
Subscription Required
References
Subscription Required
Last Reviewed:04/30/2019
Last Updated:09/23/2021
Last Updated:09/23/2021